Long-term API stockpiling and rapid finished dose form manufacture
The European Health and Digital Executive Agency (HaDEA) is planning to launch a call for tenders on "Long-term API stockpiling and rapid finished dose form manufacture", a feasibility project to assess its application in crisis preparedness. The current deadline is 29 Sep 2026, 15:00 UTC. The listed estimated value is €6,000,000.
What the buyer needs
- The European Health and Digital Executive Agency (HaDEA) is planning to launch a call for tenders on "Long-term API stockpiling and rapid finished dose form manufacture", a feasibility project to assess its application…
- This project aims to support the development of and access to technologies that can prolong the shelf-life of Active Pharmaceutical Ingredients (APIs) stored in bulk and advanced manufacturing technologies to produce…
- The upcoming call for tenders will request the development of a pilot feasibility project to test this concept, assess its viability, and provide recommendations on how to operationalise the approach.
Procurement signals
- Procedure: HADEA/2026/OP/0021
- Procedure type: Source procedure code 47396220
- Contract type: Services contract (31095498)
- Submission method: Electronic submission
- Published: 24 Jun 2026
Procurement categories
CPV labels are not yet mapped locally, so the official category codes are shown as source-backed identifiers.
Programme and geography
Derived from official EU Funding & Tenders portal source fields. Use this as a shortlisting aid; the official tender record remains authoritative.
Source-backed details
Original identifiers and classification fields from the EU tender source.
- HADEA/2026/OP/0021
- 0258dbd1-ced0-4239-81e1-1a76e7a71881-CN
- Source procedure code 47396220
- Services contract (31095498)
- 47352360
- Europe/Brussels
- 29 Sep 2026, 15:00 UTC
- 15 Jul 2026, 07:21 UTC
Full official description
The European Health and Digital Executive Agency (HaDEA) is planning to launch a call for tenders on "Long-term API stockpiling and rapid finished dose form manufacture", a feasibility project to assess its application in crisis preparedness. This project aims to support the development of and access to technologies that can prolong the shelf-life of Active Pharmaceutical Ingredients (APIs) stored in bulk and advanced manufacturing technologies to produce finished dose forms from those bulk APIs rapidly, enhancing crisis preparedness by exploring potential gains in sustainability, resiliency, and flexibility to respond to future health emergencies. The upcoming call for tenders will request the development of a pilot feasibility project to test this concept, assess its viability, and provide recommendations on how to operationalise the approach.